ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,536Medicare Part D Prescriptions Filled, Including Refills

Rank: 81 out of 252

$709K Total Retail Price of All Prescriptions

Rank: 50 out of 252

459 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 459 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,126 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 398 351 1 1
FUROSEMIDE 378 338 2 7
HYDROCODONE-ACETAMINOPHEN 338 216 S3 3 5
OMEPRAZOLE 326 234 4 6
SIMVASTATIN 320 235 5 2
POTASSIUM CHLORIDE 314 274 6 8
AMLODIPINE BESYLATE 258 233 7 4
NEXIUM 189 101 8 23
GABAPENTIN 174 117 9 11
METOPROLOL SUCCINATE 165 134 10 19
CITALOPRAM HBR 153 138 11 15
LISINOPRIL 147 116 12 3
METOPROLOL TARTRATE 146 118 13 10
METFORMIN HCL ER 144 121 14 74
TAMSULOSIN HCL 142 119 15 26
ALLOPURINOL 139 129 16 30
EVISTA 139 124 16 91
SERTRALINE HCL 123 101 18 27
LEVOFLOXACIN 122 79 19 79
WARFARIN SODIUM 117 103 20 14
ZOLPIDEM TARTRATE 110 78 21 21
FENTANYL 107 65 S2 22 126
AZITHROMYCIN 105 88 23 37
NAMENDA 97 97 24 41
TRAMADOL HCL 94 79 25 17
ATORVASTATIN CALCIUM 93 81 26 16
TRIAMTERENE-HCTZ 91 80 27 33
CRESTOR 90 44 28 34
MORPHINE SULFATE ER 89 47 S2 29 127
ATENOLOL 81 79 30 18
DIOVAN 81 64 30 38
CIPROFLOXACIN HCL 79 67 32 61
LOSARTAN POTASSIUM 77 76 33 24
CLOPIDOGREL 73 59 34 29
GEMFIBROZIL 69 55 35 98
CYCLOBENZAPRINE HCL 68 22 R 36 51
CARVEDILOL 68 63 36 22
PROAIR HFA 67 27 38 54
ALENDRONATE SODIUM 65 54 39 32
ESCITALOPRAM OXALATE 65 55 39 56
BENICAR 64 58 41 143
LOSARTAN-HYDROCHLOROTHIAZIDE 62 62 42 49
PLAVIX 61 58 43 43
METFORMIN HCL 61 34 43 9
DONEPEZIL HCL 60 60 45 28
QUINAPRIL HCL 59 43 46 120
MIRTAZAPINE 59 59 46 58
CYMBALTA 58 27 48 45
CLONIDINE HCL 56 51 49 35
GLIMEPIRIDE 56 37 49 40
RANITIDINE HCL 53 34 51 48
SPIRIVA 50 26 52 68
DIGOXIN 50 50 52 44
ULORIC 50 48 52 355
BYSTOLIC 50 48 52 99
LUNESTA 50 26 52 286
MELOXICAM 50 35 52 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.